Cargando…

Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone

Neuroleptic Malignant Syndrome (NMS) associated with the use of first-generation antipsychotics is a widely known phenomenon. This idiosyncratic reaction is less significant with the use of second-generation antipsychotics, and only a few cases in the literature exist, describing this reaction with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Paras, Omoruyi, Adanegbe, Perai, Kiara Gascon, MacDaid, Kerenza, Burton, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102093/ https://www.ncbi.nlm.nih.gov/pubmed/34007505 http://dx.doi.org/10.1155/2021/5584104

Ejemplares similares

“Neuroleptic Malignant Syndrome (NMS) Sans Rigidity”……Does it Exist??
por: Shaik, Reshma Sultana, et al.
Publicado: (2022)

Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine
por: Leonardo, Quevedo-Florez, et al.
Publicado: (2017)

A Case Report on Neuroleptic Malignant Syndrome (NMS): How to Approach an Early Diagnosis
por: Paul, Tanya, et al.
Publicado: (2022)

Clozapine Induced Neuroleptic Malignant Syndrome
por: Jo, Yong Suk, et al.
Publicado: (2017)

Case report on clozapine-associated neuroleptic malignant syndrome
por: Wang, Yanqiong, et al.
Publicado: (2012)

Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report
por: Langan, Julie, et al.
Publicado: (2012)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

Paliperidone Inducing Concomitantly Syndrome of Inappropriate Antidiuretic Hormone, Neuroleptic Malignant Syndrome, and Rhabdomyolysis
por: Kaur, Jaspinder, et al.
Publicado: (2016)

Development of Neuroleptic Malignant Syndrome in a Patient with Lewy Body Dementia after Intramuscular Administration of Paliperidone
por: Yeung, Ho-Man, et al.
Publicado: (2021)

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
por: Cheng, Minfeng, et al.
Publicado: (2016)

THE POSSIBILITY OF THE EVOLUTION OF NEUROLEPTIC MALIGNANT SYNDROME DURING THE CONCOMITANT USE OF CLOZAPINE WITH LITHIUM SALTS
por: Tomcuk, A., et al.
Publicado: (2023)

NMS pediatría
Publicado: (2009)

An Unusual Cause of Persistent Tachycardia: Atypical Neuroleptic Malignant Syndrome
por: Duhan, Sanchit, et al.
Publicado: (2023)

An Atypical Case of Neuroleptic Malignant Syndrome Associated With Ciprofloxacin and Quetiapine
por: Rohail, Muhammad U, et al.
Publicado: (2023)

NMS medicina interna /
Publicado: (2009)

Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study
por: Kane, John M., et al.
Publicado: (2019)

Optimizing dosing in atypical neuroleptic monotherapy
por: Trémeau, Fabien, et al.
Publicado: (2002)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

Neuroleptic malignant syndrome with thyroid disorder: An unusual case report
por: Zhang, Fan, et al.
Publicado: (2017)

NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF 2 CASES
por: Deshmukh, D.K., et al.
Publicado: (1989)

Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics
por: Feng, Yuhui, et al.
Publicado: (2013)

Atypical Neuroleptic Malignant Syndrome in a COVID-19 Intensive Care Unit
por: Durbach, Joshua R, et al.
Publicado: (2022)

Atypical Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
por: Grant, Heidi
Publicado: (2023)

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
por: Sarkar, Siddharth, et al.
Publicado: (2017)

CERN NMS Summer School 2018
por: Caraban Gonzalez, Noemi
Publicado: (2018)

Meeting with NMS Summer Student 2019
por: Badinova, Eszter
Publicado: (2019)

CERN NMS Summer School 2019
por: Brice, Maximilien
Publicado: (2019)

Fundamentals of EMS, NMS and OSS/BSS
por: Sathyan, Jithesh
Publicado: (2011)

Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis
por: Kobayashi, Remiko, et al.
Publicado: (2020)

Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment
por: Sahoo, Manoj Kumar, et al.
Publicado: (2014)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)

Atypical Neuroleptic Malignant Syndrome in the Setting of Quetiapine Overdose: A Case Report and Review of the Literature
por: Hernandez, Sheila D, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient
por: Espiridion, Eduardo D, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman
por: Burad, Jyoti, et al.
Publicado: (2021)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Julius Baer meeting with NMS Summer Students
por: Nirta, Benedetta
Publicado: (2018)

RESOLUTION OF SYMPTOMS IN NMS : A CASE REPORT
por: Das, Arunava, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_d53uk0857b5sjs42ens1qhc31l